pharma Drug price caps: The Wrong Approach to Cancer Treatment Drug price caps are crucial, but the focus must extend beyond cancer drugs for better… Vincent HughesOctober 14, 2026
pharma Cancer drug prices may fall: A clear path to affordability Cancer drug prices may soon drop significantly, making treatments more accessible for patients. Vincent HughesOctober 9, 2026
pharma Is Lantheus Bravnetsa Approval a Safe and Proven Option? Lantheus Bravnetsa approval marks a significant advancement in treatment options. Discover its implications and benefits. Vincent HughesSeptember 24, 2026
pharma FDA Approval Delay: What It Means for Colorectal Cancer Patients FDA approval delay impacts treatment options for colorectal cancer. Vincent HughesSeptember 17, 2026
pharma Bayer lung cancer drug approval: Safe and Proven Solution Bayer lung cancer drug approval expands treatment options for patients. Vincent HughesSeptember 10, 2026